Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study.

14 Mar 1994Schreinemachers, Dina M.; Everson, Richard B.

Incidence of several cancers was lower among persons who reported aspirin use: the incidence rate ratios (and 95% confidence intervals) for all sites combined were 0.83 (0.74-0.93), lung cancer 0.68 (0.49-0.94), breast cancer in women 0.70 (0.50-0.96), and colorectal cancer in younger men 0.35 (0.17-0.73).

Cohort Study
3 effects
12 years 5 months
12668 subjects

Reported Outcomes

VariablesOutcomeEffectLatency

Aspirin Manufactured risk & protective factor
Aspirin
Manufactured

Breast Cancer Reproductive outcome
Breast Cancer
Reproductive

Strong Decrease

Login required to view

Aspirin Manufactured risk & protective factor
Aspirin
Manufactured

Lung cancer Respiratory outcome
Lung cancer
Respiratory

Strong Decrease

Login required to view

Aspirin Manufactured risk & protective factor
Aspirin
Manufactured

Colorectal Cancer Digestive outcome

Strong Decrease

Login required to view